Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Medical Bud News.
Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
GlobeNewswire, Inc.
·
August 12, 2025
New York, USA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Cannabinoids are specific chemical compounds found in cannabis, such as...
Horizon Specialty Seeds to Showcase Certified Hemp and Flax Varieties at NDSU Fiber Roundtable, August 20
EIN Presswire
·
August 13, 2025
Horizon Specialty Seeds, a leading certified flax and hemp seed provider, will participate in the 2025 NDSU Fiber Roundtable and Hemp & Flax Fiber Tour. CLARK, SD, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Horizon Specialty Seeds, a...
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts
GlobeNewswire, Inc.
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare...
Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company’s Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of Anxiety and Depression
GlobeNewswire, Inc.
·
August 1, 2025
SOLANA BEACH, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (“Artelo” or the “Company”) (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people...
SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
GlobeNewswire, Inc.
·
July 30, 2025
TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the...
Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea
GlobeNewswire, Inc.
·
August 8, 2025
MELBOURNE, Australia and NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage pharmaceutical company developing innovative combination therapies for prevalent medical conditions, today announced new...
Postoperative Pain Management Market Poised for Transformation During the Forecast Period (2025–2034) with Rising Non-Opioid Adoption | DelveInsight
GlobeNewswire, Inc.
·
August 7, 2025
New York, USA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Postoperative Pain Management Market Poised for Transformation During the Forecast Period (2025–2034) with Rising Non-Opioid Adoption | DelveInsight The postoperative pain management market is...
Grön Handcrafted Medical Marijuana Infused Troches Debuts In Pennsylvania
GlobeNewswire, Inc.
·
August 7, 2025
PORTLAND, Ore., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Grön (pronounced grewn), one of America’s fastest growing medical marijuana brands, today announced its official launch in the Pennsylvania medical cannabis market. This week, Grön Troches will be...
DOH ANNOUNCES FREE MEDICAL CANNABIS CME/CE COURSES FOR HAWAIʻI HEALTHCARE PROVIDERS
Hawaii State Department of Health
·
August 6, 2025
Posted on Aug 6, 2025 in Newsroom HONOLULU — The Hawaiʻi Department of Health (DOH) is now offering free accredited Continuing Medical Education (CME) and Continuing Education (CE) courses on medical cannabis to licensed healthcare providers in...
Chronic Pain Associated with Painful Diabetic Neuropathy Market Sees is Predicted to Surge During the Forecast Period (2025–2034) with New Treatment Innovations and Expanding Research Spending | DelveInsight
GlobeNewswire, Inc.
·
July 31, 2025
New York, USA, July 31, 2025 (GLOBE NEWSWIRE) -- Chronic Pain Associated with Painful Diabetic Neuropathy Market Sees is Predicted to Surge During the Forecast Period (2025–2034) with New Treatment Innovations and Expanding Research Spending |...
Texans Deserve Choice, Not a Monopoly: Texas Hemp Business Council Urges Lawmakers to Defeat SB 5
GlobeNewswire, Inc.
·
July 29, 2025
AUSTIN, Texas, July 28, 2025 (GLOBE NEWSWIRE) -- The Texas Hemp Business Council (THBC) today issued the following statement: "As SB 5 heads to the Senate floor during the special session of the 89th Texas Legislature, Lt. Governor Dan Patrick and...
Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo
GlobeNewswire, Inc.
·
July 25, 2025
NEW YORK and MELBOURNE, Australia, July 25, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact...
USPTO Grants Patent for Novel Therapeutics for Antibody-Cannabinoid Conjugates
EIN Presswire
·
July 28, 2025
Diverse Biotech Emerging as Leader in Cannabinoid Drug Conjugate Space With Landmark Patent MIAMI, FL, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- Diverse Biotech Inc., an innovative developer in novel drug technology, today announced a...
NKGen Receives FDA Expanded Access Protocol Authorization for Landmark Treatment of Several Neurodegenerative Diseases
GlobeNewswire, Inc.
·
July 21, 2025
Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in Alzheimer’s Disease. Company receives expanded...
Avicanna Reports Q2 2025
GlobeNewswire, Inc.
·
August 14, 2025
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived...
Artelo Biosciences Provides Business Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire, Inc.
·
August 13, 2025
SOLANA BEACH, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain,...
Best Plumbing Contractor Business Loans: ROK Financial Expands No Credit Check Financing Access for Companies Facing Credit Challenges
GlobeNewswire, Inc.
·
August 16, 2025
LOS ANGELES, Aug. 16, 2025 (GLOBE NEWSWIRE) -- The information below is provided for general informational purposes only and does not constitute financial or professional advice. Funding availability, terms, and approval times may vary by...
Artelo Biosciences Receives Notice of Allowance from European Patent Office for the Patent Claims for the Intended Commercial Formulation of ART27.13
GlobeNewswire, Inc.
·
August 11, 2025
Extends Patent Protection Through December 2041 ART27.13 is Currently under Evaluation in a Phase 2 Study for the Treatment of Cancer-Related Anorexia SOLANA BEACH, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL),...
Avicanna Announces US Patent and Trademark Office Issuance of New Patent
GlobeNewswire, Inc.
·
August 11, 2025
USPTO Issues Patent No. US 12,343,315 B2 covering topical cannabinoid compositions for clear skin TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company...
Grön Expands CBN Edible Line with New Wildberry Pearls
GlobeNewswire, Inc.
·
August 12, 2025
PORTLAND, Ore., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Grön (pronounced grewn), America’s fastest growing cannabis edibles brand, today announced the launch of Wildberry Pearls, the company’s newest nighttime edible designed to support deep,...